The adenine nucleotides AMP, ADP, and ATP exert various
effects on AMPK activity [11, 12]. Moreover, the cellular energy
levels are better reflected by AMP:ATP and ADP:ATP ratios
[1, 25–27]. Since the levels of AMP are of extreme low ranges,
and ADP, as well as ATP, is rather unstable, it is challenging to
precisely measure the levels of AMP, ADP, and ATP. Here, we
describe a sensitive method for determining the cellular levels of
AMP, ADP, and ATP by using the capillary electrophoresis-mass
spectrometry (CE-MS)-based assays [28, 29].
All of the methods described here are summarized in Fig.1.Of
note, for simplicity, we only mention glucose starvation as a repre-
sentative stress in some parts of the chapter.
To define AMPK activation
via the lysosomal pathway
To determine lysosomal
localization of AXIN/LKB1 by:
To reconstitute
lysosomal AMPK activation by:
Isolation of
lysosome
Isolation
of DRM
Detection of
lysosomal association
of AXIN/LKB1
Detection of
AMPK activation
Level of p-T172 of
AMPK on light
organelles
To obtain genetic evidence by
treating AXIN-/-or LAMTOR1-/-
MEFs and mice, followed by
detection of p-T172-AMPKα
Preparation of
light organelle
Level of
phosphorylation of
ACC by AMPK
Detection of
v-ATPase-Ragulator-AXIN
interaction
Immunofluorescent
staining
Fig. 1Diagram of workflow for studying the lysosomal AMPK activation. To study the lysosomal AMPK
activation under a desired metabolic stress or pharmacological stimulus, p-Thr-172-AMPKαand p-Ser-79-
ACC are analyzed inAXIN/andLAMTOR1/mouse embryonic fibroblasts (MEFs) or mouse individuals.
The dynamic association of the AXIN/LKB1 with the lysosomal DRM can be determined in purified lysosomes/
DRMs, as well as in intact cells. The complex formation of v-ATPase-Ragulator-AXIN/LKB1-AMPK can be
determined by co-immunoprecipitation. In addition, the light organelle-based assay system provides a way to
determine whether a particular protein or drug of interest activates AMPK directly through triggering the
lysosomal pathway in vitro
Analysis of Lysosomal AMPK Activation 395